Shenzhen Hepalink Pharmaceutical Co., Ltd., Ten Percent Owner at Liminal BioSciences, holds 85.29M shares in Resverlogix (Ticker: TSE:RVX), holds 96.29M shares in Liminal BioSciences (Ticker: LMNL). Most recently, Shenzhen Hepalink Pharmaceutical Co., Ltd. Bought ― shares of Resverlogix on Aug 18, 2020 for an estimated value of 2.68M.